Home
Featured Authors
Adrian Alvarez
Albert Pineda
Andy Mehrotra
Barri Blauvelt
C.E.L.forpharma
Christopher Horne
Donald Gonsalves
Fred Geyer
Gary Monk
Grant Johnson
Guillem Vidal
Halldor Kristmannsson
John Cahill
Jonathan Trethowan
Jorge Herrera
Julian Harrison
Julien de Salaberry
Julien Moussalli
Karen Bauer
Kevin Adema
Kevin Dolgin
Lorraine Lyons
Luca Dezzani
Macarena Fritz
Michael Kenigsberg
Mike Pile
Nancy Southerland
Natalie Yeadon
Nicolas Arkells
Rob Hoff
Editor’s Pick
Login
Search
The Pharmaceutical Marketing Group
Home
Featured Authors
All
Adrian Alvarez
Albert Pineda
Andy Mehrotra
Barri Blauvelt
C.E.L.forpharma
Christopher Horne
Donald Gonsalves
Fred Geyer
Gary Monk
Grant Johnson
Guillem Vidal
Halldor Kristmannsson
John Cahill
Jonathan Trethowan
Jorge Herrera
Julian Harrison
Julien de Salaberry
Julien Moussalli
Karen Bauer
Kevin Adema
Kevin Dolgin
Lorraine Lyons
Luca Dezzani
Macarena Fritz
Michael Kenigsberg
Mike Pile
Nancy Southerland
Natalie Yeadon
Nicolas Arkells
Rob Hoff
Featured Articles
Virtual Trials as a Means to Increase Patient Involvement and Reduce…
Featured Articles
10 Things I Learned About Digital Health in Brazil
Featured Authors
Five Essential Skills for Pharma’s Future Leaders
Featured Articles
“Magic Mushrooms” for Psychotherapy—What Does the Evidence Say?
Editor’s Pick
Editor’s Pick
LYNPARZA® (olaparib) Approved in the EU for Use as First-Line Maintenance…
Editor’s Pick
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Monotherapy for Patients with Metastatic…
Editor’s Pick
Roche wins Japan approval for personalized cancer drug Rozlytrek
Editor’s Pick
AstraZeneca’s Lynparza gets EU nod as first-line ovarian cancer maintenance treatment
Editor’s Pick
French drugmaker Sanofi, Google to use data tech for innovations
Login
20.6
C
New York
Tuesday, June 18, 2019
- Advertisement -
Login
Username or Email
Password
Remember Me
Lost password?
Log In
Create New Account
